159 filings
Page 4 of 8
8-K
r42csdaxu6daj
6 Nov 06
Other Events
12:00am
8-K/A
diz3675r08kqlnuqihn2
1 Nov 06
Financial Statements and Exhibits
12:00am
8-K
tenlz6rbuc7a
12 Oct 06
Oscient Pharmaceuticals Provides Preliminary Revenue Results for Third Quarter 2006
12:00am
8-K
biv6tub353y ta
22 Sep 06
Oscient Pharmaceuticals Receives Approvable Letter from FDA for FACTIVE® Tablets for Five-Day Treatment of Community-Acquired Pneumonia
12:00am
8-K
o9zess1n6rx9k
13 Sep 06
Other Events
12:00am
8-K
q73ehtcn
11 Sep 06
Other Events
12:00am
8-K
plng7azm7xw481
5 Sep 06
Oscient Pharmaceuticals and Auxilium Pharmaceuticals Agree to Conclude
12:00am
8-K
b1k8eeh 3a6hl
21 Aug 06
Oscient Pharmaceuticals Completes Acquisition of Cardiovascular Therapy
12:00am
8-K
q7p1pvs70ms
10 Aug 06
Entry into a Material Definitive Agreement
12:00am
8-K
p3swix
9 Aug 06
Oscient Pharmaceuticals Reports Financial Results for Second Quarter and First Half of 2006
12:00am
8-K
imxhi ub27a34ihi
1 Aug 06
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce
12:00am
8-K
krwiirkvy1c4iru rj
25 Jul 06
Oscient Pharmaceuticals Agrees to Acquire Cardiovascular Therapy ANTARA® 130 mg
12:00am
8-K
cwszfrkhxu9o3 gy1k
30 Jun 06
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address
12:00am
8-K
zuxuns8p 6b
14 Jun 06
William R. Mattson, Jr. Elected to Oscient Pharmaceuticals Board of Directors
12:00am
8-K
9bm j699o
24 May 06
Entry into a Material Definitive Agreement
12:00am
8-K
w52aqk
10 May 06
Oscient Pharmaceuticals Reports Financial Results for First Quarter
12:00am
8-K
h29vj9
12 Apr 06
Oscient Pharmaceuticals Announces $35 Million Private Placement Financing
12:00am
8-K
frgwavxg
5 Apr 06
Oscient Pharmaceuticals’ FACTIVE Tablets Subject of Poster Presentations at European
12:00am
8-K
oxl9glruby7i5v8
8 Mar 06
Oscient Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2005
12:00am
8-K
sjhzsba 2y4ig
8 Feb 06
Oscient Pharmaceuticals Acquires Expanded Worldwide Rights to
12:00am